Suchergebnisse - "Davies, Jane C"

PubPharm (275)

31

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin Against Cystic Fibrosis Pseudomonas aeruginosa

enthalten in: bioRxiv.org | 2022

von Murphy, R. | Coates, M. | Thrane, S. | +6

32

Selection of Relevant Bacterial Strains for Novel Therapeutic Testing: a Guidance Document for Priority Cystic Fibrosis Lung Pathogens

enthalten in: Current clinical microbiology reports | 2022

von Mahenthiralingam, E. | Weiser, R. | Floto, R. | +2

33

Selection of Relevant Bacterial Strains for Novel Therapeutic Testing: a Guidance Document for Priority Cystic Fibrosis Lung Pathogens

enthalten in: Current clinical microbiology reports | 2022

von Mahenthiralingam, E. | Weiser, R. | Floto, R. | +2

34

Progress in Respiratory Gene Therapy

enthalten in: Human gene therapy | 2022

von McLachlan, G. | Alton, E. | Boyd, A. | +8

35

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa

enthalten in: Microbiology spectrum | 2022

von Murphy, R. | Coates, M. | Thrane, S. | +6

36

Going the Extra Mile : Why Clinical Research in Cystic Fibrosis Must Include Children

enthalten in: Children (Basel, Switzerland) | 2022

von Dobra, R. | Bentley, S. | Edmondson, C. | +6

37

A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022

von Sawicki, G. | Chilvers, M. | McNamara, J. | +10

38

An Update on CFTR Modulators as New Therapies for Cystic Fibrosis

enthalten in: Paediatric drugs | 2022

von King, J. | Nichols, A. | Bentley, S. | +2

39

Large scale clinical trials : lessons from the COVID-19 pandemic

enthalten in: BMJ open respiratory research | 2022

von Horsley, A. | Pearmain, L. | Knight, S. | +14

40

Impact of cross-sensitivity error correction on representative nitrogen-based multiple breath washout data from clinical trials

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022

von Robinson, P. | Jensen, R. | Seeto, R. | +5